The unmet need for therapies capable of repairing the central nervous system (CNS)
damage occurring in many diseases including multiple sclerosis (MS) has sparked the …

Developing effective therapies for serious neurological insults remains a major challenge for
biomedical research. Despite intense efforts, the ability to promote functional recovery after …

The rationale for use of adult stem cells as a treatment for neurological diseases such as
multiple sclerosis arose from the hope that they had the capacity to foster repair of the CNS …

Neurological disorders are becoming a growing burden as society ages, and there is a
compelling need to address this spiraling problem. Stem cell‐based regenerative medicine …

Mesenchymal stem cells resident in adult bone marrow are best characterized by their
capacity to differentiate into connective tissue cell types such as adipocytes, chondrocytes …

Complex circuitry and limited regenerative power make central nervous system (CNS)
disorders the most challenging and difficult for functional repair. With elusive disease …

Stem cell-based therapies for neurodegenerative diseases aim at halting clinical
deterioration by regeneration and by providing local support for damaged tissue …

Here we provide a comprehensive data on the unique features of mesenchymal stem cells
(MSCs) which makes them feasible and preferred candidate for cell-based therapy in …

There may be the potential to improve stroke recovery with mesenchymal stem cells (MSCs);
however, questions about the efficacy and safety of this treatment remain. To address these …

Multiple sclerosis (MS) is a disease of the central nervous system (CNS) that is the result of
the body's own immune cells being auto-reactive to the myelin regions of the body as if …